Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie (prior sponsor, Abbott)
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The subject was randomized into Study M10-346 and completed the study.
Female subjects of childbearing potential must have a negative urine pregnancy test at screening and baseline and agree to comply with applicable contraceptive requirements.
Male subjects must agree to comply with applicable contraceptive requirements.
The subject is judged to be in generally good health.
You may not be if
The subject has taken any ADHD medication between the last dose of study drug in Study M10-346 and the first dose of study drug in the current study.
The subject anticipates a move outside the geographic area.
Clareo Health | Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
